The Department of Atomic Energy (DAE), in partnership with IDRS Labs, has introduced `AKTOCYTE`, a nutritional supplement designed to improve the quality of life for cancer patients undergoing radiotherapy. AKTOCYTE has been certified by the Food Safety and Standards Authority of India (FSSAI), according to an official statement, stated the PTI report. 

The launch on Wednesday was attended by scientists from the Bhabha Atomic Research Centre in Mumbai, the Advanced Centre for Training, Research, and Education in Cancer in Navi Mumbai, Tata Memorial Hospital in Mumbai, and officials from IDRS Labs, all of whom contributed to the tablet development.